Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Andera Partners
Form 13F · Q2 2026

Andera Partners

CIK 1757283Filed 2026-07-2213F-HR View the filing on EDGAR ↗
$206M
Reported book value
8
Positions
3
Quarters on record
Top 50
Positions

Andera Partners — holdings

Top 8 positions of 8, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1KESTRA MED TECHNOLOGIES LTD Kestra Med Technologies Ltd2.7M+1.2%$69M33.6%
2MLYS Mineralys Therapeutics Inc1.6M+0.0%$43M20.8%
3AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc929,824—$31M14.8%
4AGMB Agomab Therapeutics Nv1.5M+0.0%$20M9.7%
5EVMN Evommune Inc1.4M−26.6%$18M9.0%
6IVA Inventiva Sa3.6M+99.8%$14M6.7%
7ABIVAX SA Abivax Sa78,125+0.0%$10M5.0%
8NYXH Nyxoah S A522,057+0.0%$882,2760.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.